If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
4,714.00    -186.00 (-3.80%)
Bid:
4,708.00
Ask:
4,718.00
Spread: 10.00 (0.212%)
Market Cap: £3.43b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

13 Oct 2011 11:05

RNS Number : 1203Q
Renishaw PLC
13 October 2011
 



 

Renishaw plc

Interim management statement

 

This statement has been prepared for the Group and relates to the three months ended 30th September 2011. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

Revenue for the three months to 30th September 2011 was £70.5m, an increase of 15.0% over the £61.3m for the first quarter of the previous year but below planned-for revenue. The previous year has been restated for the inclusion of Measurement Devices Limited from July 2010, which was initially accounted for as an associate company.

 

Geographically, Europe reported growth of 26% over the comparable period last year and the Americas a growth of 21%. The Far East, an area of significant growth last year, showed revenue for this quarter at a similar level to the corresponding quarter last year. By market sector, we have seen a slowdown in one of our product lines sold to the electronics industries.

 

Profit before tax for the first quarter amounted to £13.6m, compared with £15.1m last year.

 

The Group has increased its cost base compared with the comparable period last year, mainly by the addition of personnel to support its growing revenue and production demands, and investment in its research and development programmes. Headcount at the end of September 2011 was 2,745, an increase of 70 from the start of the financial year at 1st July 2011 and an increase of 538 over the 2,207 personnel at 30th September 2010.

 

Significant events and financial position

We are reviewing our healthcare business and have refocused part of the activities to a smaller number of projects, with some resources diverted to our metrology business.

 

The purchase of the Miskin premises, close to Cardiff in South Wales, was completed on 30th September 2011 and the Group also acquired premises for its Canadian and Italian subsidiaries. The aggregate cost of these acquisitions was £9.0m.

 

The Group continues to have a strong balance sheet with net cash balances at 30th September 2011 of £29.3m (30th June 2011 £34.6m).

 

I should like to thank our staff for their continuing efforts and support.

 

Outlook

It is still very early in the financial year and the Group traditionally has an order book of a little over one month's sales value. During the first quarter order intake has exceeded revenue and the Group has an order book of £31.9m at the end of September 2011.

 

Due to current uncertainties surrounding the global economy, the Board is closely monitoring the Group's costs and future recruitment strategy. Despite near-term challenges caused by the economic environment, we remain focused on positioning the Group for further long-term growth.

 

 

 

 

 

Sir David McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

 

13th October 2011

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMJBMTMBMBBIB
Date   Source Headline
26th May 200912:23 pmRNSHolding(s) in Company
15th May 20097:00 amRNSInterim Management Statement
14th May 20092:11 pmRNSDirectorate Change
30th Mar 20092:08 pmRNSHolding(s) in Company
11th Mar 20098:00 amRNSTrading Statement
9th Feb 20092:29 pmRNSPatent litigation settlement
28th Jan 20097:30 amRNSHalf Yearly Report
23rd Jan 20093:32 pmRNSTrading statement & Interim results preview
24th Nov 20085:48 pmRNSAcquisition
30th Oct 20089:50 amRNSDirector/PDMR Shareholding
14th Oct 20084:43 pmRNSSecond Price Monitoring Extn
14th Oct 20084:38 pmRNSPrice Monitoring Extension
10th Oct 20081:11 pmRNSResult of AGM
10th Oct 20087:30 amRNSInterim Management Statement
4th Sep 200810:18 amRNSAnnual Information Update
18th Aug 20088:47 amRNSAnnual Report and Accounts
23rd Jul 20087:30 amRNSFinal Results
20th Jun 20088:10 amRNSDirectorate Change
19th Jun 20088:38 amRNSPatent legal proceeedings
8th May 20084:20 pmRNSStatement -Voting arrangement
8th May 20087:30 amRNSInterim Management Statement
6th May 20088:59 amRNSHolding(s) in Company
3rd Apr 20083:06 pmRNSHolding(s) in Company
3rd Apr 20082:28 pmRNSHolding(s) in Company
3rd Apr 20082:19 pmRNSDirector/PDMR Shareholding
25th Mar 20082:20 pmRNSHolding(s) in Company
21st Feb 20088:18 amRNSHolding(s) in Company
28th Jan 20082:10 pmRNSHolding(s) in Company
23rd Jan 20087:30 amRNSInterim Results
12th Oct 20072:41 pmRNSResult of AGM
12th Oct 200710:44 amRNSHolding(s) in Company
12th Oct 200710:43 amRNSHolding(s) in Company
12th Oct 20077:00 amRNSInterim Management Statement
20th Sep 20071:46 pmRNSNotice of EGM
7th Sep 200710:05 amRNSAnnual Information Update
17th Aug 20073:50 pmRNSAnnual Report and Accounts
25th Jul 20073:22 pmRNSHolding(s) in Company
25th Jul 20077:30 amRNSFinal Results
9th Jul 20074:30 pmRNSAcquisition
9th Jul 20071:53 pmRNSHolding(s) in Company
13th Jun 200711:26 amRNSHolding(s) in Company
11th Jun 20072:32 pmRNSTrading Statement
4th Jun 200711:42 amRNSRelated Party Transaction
24th Apr 200711:16 amRNSHolding(s) in Company
23rd Apr 200711:46 amRNSIssue of Equity
30th Mar 20078:17 amRNSAcquisition
27th Mar 20072:10 pmRNSHolding(s) in Company
20th Mar 20071:39 pmRNSHolding(s) in Company
9th Mar 20078:49 amRNSHolding(s) in Company
9th Mar 20078:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.